Farmers & Merchants Investments Inc. Sells 4,865 Shares of Aflac Incorporated (NYSE:AFL)

Farmers & Merchants Investments Inc. trimmed its holdings in shares of Aflac Incorporated (NYSE:AFLFree Report) by 3.0% during the fourth quarter, HoldingsChannel reports. The fund owned 155,308 shares of the financial services provider’s stock after selling 4,865 shares during the quarter. Farmers & Merchants Investments Inc.’s holdings in Aflac were worth $12,813,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AFL. Fortitude Family Office LLC bought a new stake in shares of Aflac in the fourth quarter worth $25,000. CoreFirst Bank & Trust bought a new position in Aflac during the 4th quarter worth $25,000. Studio Investment Management LLC acquired a new position in Aflac during the 4th quarter worth about $27,000. Impact Partnership Wealth LLC grew its position in shares of Aflac by 471.4% in the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock valued at $31,000 after buying an additional 330 shares during the last quarter. Finally, Bruce G. Allen Investments LLC acquired a new stake in shares of Aflac in the fourth quarter valued at about $32,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Aflac

In related news, Director Arthur Reginald Collins sold 3,000 shares of Aflac stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total transaction of $239,190.00. Following the sale, the director now directly owns 5,592 shares in the company, valued at $445,850.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Aflac news, Director Masatoshi Koide sold 30,493 shares of Aflac stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the sale, the director now owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction that occurred on Thursday, February 22nd. The shares were sold at an average price of $79.73, for a total transaction of $239,190.00. Following the transaction, the director now directly owns 5,592 shares of the company’s stock, valued at $445,850.16. The disclosure for this sale can be found here. Insiders have sold 46,493 shares of company stock worth $3,765,706 in the last 90 days. Insiders own 0.80% of the company’s stock.

Aflac Price Performance

AFL opened at $85.18 on Thursday. Aflac Incorporated has a 1 year low of $63.08 and a 1 year high of $86.26. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.06 and a quick ratio of 0.06. The company has a market capitalization of $49.01 billion, a price-to-earnings ratio of 10.99, a P/E/G ratio of 2.33 and a beta of 0.91. The firm’s fifty day moving average price is $81.81 and its two-hundred day moving average price is $81.06.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same period in the previous year, the company posted $1.29 earnings per share. As a group, analysts anticipate that Aflac Incorporated will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

AFL has been the subject of a number of analyst reports. Raymond James raised their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. UBS Group boosted their price target on shares of Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Wells Fargo & Company increased their price objective on shares of Aflac from $82.00 to $83.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 6th. Morgan Stanley decreased their price target on shares of Aflac from $85.00 to $80.00 and set an “equal weight” rating for the company in a research note on Friday, March 1st. Finally, StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a report on Thursday, March 28th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Aflac presently has a consensus rating of “Hold” and an average price target of $80.36.

Check Out Our Latest Stock Analysis on Aflac

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.